Filing Details

Accession Number:
0001225208-17-003412
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-15 16:58:41
Reporting Period:
2017-02-13
Filing Date:
2017-02-15
Accepted Time:
2017-02-15 16:58:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
9892 Bard C R Inc BCR Surgical & Medical Instruments & Apparatus (3841) 221454160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403373 A John Deford C/O C. R. Bard, Inc.
730 Central Avenue
Murray Hill NJ 07974
Sr. Vp Sci Tech And Clin Afrs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-13 447 $240.47 24,684 No 4 F Direct
Common Stock Disposition 2017-02-13 1,897 $240.47 22,318 No 4 F Direct
Common Stock Disposition 2017-02-14 2,788 $240.51 19,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 74 Indirect 401(k) Plan
Footnotes
  1. Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
  2. Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
  3. Sales are pursuant to a previously disclosed 10b5-1 plan.
  4. Represents the weighted average sales price for price increments ranging from $240.33 to $240.85. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.